题目：Recent Advances in Catalomics

报告人：Shao Qin Yao教授

时间：05月29日（周五）上午09:00

地点：401号楼一楼会议室

         欢迎广大师生踊跃参加！

                                                医学部欧洲杯官网

                                                放射医学及交叉学科研究院

报告摘要：Sequencing of the human genome provided a wealth of information about the genomic blueprint of a cell. But genes do not tell the entire story of life and living processes; identifying the roles of enzymes and mapping out their interactions is also crucial. Enzymes catalyze virtually every cellular process and metabolic exchange. They not only are instrumental in sustaining life but also are required for its regulation and diversification. Diseases such as cancer can be caused by minor changes in enzyme activities. In addition, the unique enzymes of pathogenic organisms are ripe targets for combating infections. Consequently, nearly one-third of all current drug targets are enzymes. Little, however, is understood about the physiological roles, substrate specificity, and downstream targets of the vast majority of these important proteins. A key step toward the biological characterization of enzymes, as well as their adoption as drug targets, is the development of global solutions that bridge the gap in understanding these proteins and their interactions. Catalomics is an emerging field in chemical biology in which chemical and biological tools are developed, enabling large-scale studies of enzymes at the organism level. In this presentation, I will discuss latest progress made in my laboratory in relation to drug discovery. Specifically, I will discuss our recent results on using microarray-based technologies for discovery of potential drug candidates. In addition, I will describe our recent strategy on the development of small molecule chemical probes for cell-based proteome profiling of potential drug targets (on and off), and imaging applications.

报告人简介：

Shao Qin Yao, Professor, Department of Chemistry, National University of Singapore (NUS). He received his B.Sc. with honors from Ohio State University (USA) in 1993 and his PhD from Purdue University (USA) in 1998. His PhD research involved Bioorganic Chemistry and de novo peptide & protein design, working under the supervision of Prof. Jean A. Chmielewski. After obtaining a fellowship from CRI (Cancer Research Institute, USA) in 1998, he carried out his post-doctoral research first at University of California, Berkeley, then at Scripps Research Institute (USA), both under the supervision of Prof.   Peter G Schultz..

 His current research interests include Combinatorial Chemistry, Chemical Biology & Functional  Genomics.